Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
US11603385B2 · kind B2 · utility
0Cited by
11References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 2, 2020 |
| Grant date | Mar 14, 2023 |
| Priority date | — |
| Expiry date | Sep 3, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/6951
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention provides compositions and methods for alleviating pain. Specifically, the subject invention provides pharmaceutical formulations of peptides, and/or their salts, having advantageous μ-opioid receptor binding activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.